Construction of bioartificial renal tubule assist device In Vitro and its function of transporting sodium and glucose

Abstract

To explore a new way of constructing bioartificial renal tubule assist device (RAD) in vitro and its function of transporting sodium (Na⁺) and glucose and to evaluate the application of atomic force microscope in the RAD construction, rat renal tubular epithelial cell line NRK-52E was cultured in vitro, seeded onto the outer surfaces of hollow fibers in a bioreactor, and then cultured for two weeks to construct RAD. Bioreactor hollow fibers without NRK-52E cells were used as control. The morphologies of attached cells were observed with scanning electron microscope, and the junctions of cells and polysulfone membrane were observed with atomic force microscope. Transportation of Na⁺ and glucose was measured. Oubaine and phlorizin were used to inhibit the transporting property. The results showed that NRK-52E cells and polysulfone membrane were closely linked, as observed under atomic force microscope. After exposure to oubaine and phlorizin, transporting rates of Na⁺ and glucose were decreased significantly in the RAD group as compared with that in the control group (P<0.01). Furthermore, when the inhibitors were removed, transportation of Na⁺ and glucose was restored. It is concluded that a new RAD was constructed successfully in vitro, and it is able to selectively transport Na⁺ and glucose.

Keywords

bioartificial renal tubule assist device / renal tubular epithelial cell line / transport / bioreactor / cell therapy

References

[1] LameireN., Van BiesenW., VanholderR.. Acute renal failure. Lancet, 2005, 365: 417-430

[2] FissellW.H., HumesH.D., FleischmanA.J., et al.. Dialysis and nanotechnology: now, 10 years, or never?. Blood Purif, 2007, 25(1): 12-17

[3] HumesH.D., MackayS.M., FunkeA.J., et al.. The bioartifiacial renal tubule assist device to enhance CRRT in acute renal failure. Ren Fail, 1996, 18(4): 405-408

[4] HumesH.D., MackayS.M., FunkeA.J., et al.. Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kidney Int, 1999, 55(6): 2502-2514

[5] TiranathanagulK., DhawanV., LytleI.F., et al.. Tissue engineering of an implantable bioartificial hemofilter. ASAIO J, 2007, 53(2): 176-186

[6] TumlinJ., WaliR., WilliamsW., et al.. Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Soc Nephrol, 2008, 19: 1034-1040

[7] IssaN., MesserJ., PaganiniE.P.. Renal assist device and treatment of sepsis-induced acute kidney injury in intensive care units. Contrib Nephrol, 2007, 156: 419-427

[8] DongX.G., ChenJ.H., HeQ., et al.. Retrospect and prospect of ten years’ research in bioartificial renal tubule assist device. Int J Transplant Hemopurif (Chinese), 2008, 6(2): 41-42

[9] Dong XG, Chen JH, He Q, et al. Determination of the cell viability in bioartificial renal tubule assist device by MTT assay. Bull Sci Technol (Chinese), 2009,25(5) in press

[10] DongX.G., ChenJ.H., HeQ., et al.. Evaluation on methods for the morphological observation of polysulfone hollow fiber membrane in hemofilter. Bull Sci Technol (Chinese), 2008, 24(5): 636-640

[11] FissellW.H., FleischmanA.J., HumesH.D., et al.. Development of continuous implantable renal replacement: past and future. Transl Res, 2007, 150(6): 327-336

[12] HumesH.D., FissellW.H., TiranathanagulK.. The future of hemodialysis membranes. Kidney Int, 2006, 69(7): 1115-1119

[13] TiranathanagulK., EiamO.S., HumesH.D., et al.. The future of renal support high-flux dialysis to bioartificial kidneys. Crit Care Clin, 2005, 21(2): 379-394

[14] FissellW.H., ManleyS., WestoverA.J., et al.. Differentiated growth of human renal tubule cells on thin film and nanostructured materials. ASAIO J, 2006, 52(3): 221-227

[15] DingF., HumesH.D.. The bioartificial kidney and bioengineered membranes in acute kidney injury. Nephron Exp Nephrol, 2008, 109(4): e118-e122

[16] MaoH., WangX.Y., YingX., et al.. Effect of continuous bioartificial kidney therapy on porcine multiple organ dysfunction syndrome with acute renal failure. ASAIO J, 2007, 53(3): 329-334

[17] SaitoA., AungT., SekiguchiK., et al.. Present status and perspectives of bioartificial kidneys. J Artif Organs, 2006, 9(3): 130-135

[18] SaitoA., AungT., SekiguchiK., et al.. Present status and perspective of the development of a bioartificial kidney for chronic renal failure patients. Ther Apher Dial, 2006, 10(4): 342-347

[19] FissellW.H., LouL., AbrishamiS.. Bioartificial kidney ameliorates gram-negative bacteria induced septic shock in uremic animals. J Am Soc Nephrol, 2003, 14(2): 454-461

[20] HumesH.D., WeitzelW.F., BartlettR.H., et al.. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int, 2004, 66(4): 1578-1588

[21] HumesH.D., WeitzelW.F., FissellW.H., et al.. Renal cell therapy in the treatment of patients with acute and chronic renal failure. Blood Purif, 2004, 22(1): 60-72

[22] QuanA., QuigleyR.. Renal replacement therapy and acute renal failure. Curr Opin Pediatr, 2005, 17(2): 205-209

[23] HodgesS.J., AtalaA.. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Curr Urol Rep, 2006, 7(1): 41-42

[24] FissellW.H., ManleyS., WestoverA., et al.. Differentiated growth of human renal tubule cells on thin-film and nanostructured materials. ASAIO J, 2006, 52(3): 221-227

[25] UedaH., WatanabeJ., KonnoT., et al.. Asymmetrically functional surface properties on biocompatible phospholipid polymer membrane for bioartificial kidney. J Biomed Mater Res A, 2006, 77(1): 19-27